This trial will compare the effects of olezarsen versus placebo on fasting triglyceride levels.
1 Primary · 10 Secondary · Reporting Duration: Month 6 and Month 12
Experimental Treatment
Non-Treatment Group
390 Total Participants · 2 Treatment Groups
Primary Treatment: Olezarsen · Has Placebo Group · Phase 3
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: